Pura Vida Investments, LLC Ardelyx, Inc. Transaction History

Pura Vida Investments, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $29,500 - $72,000	50,000 New	50,000 $60,000
Q1 2022 May 16, 2022	SELL	$0.65 - $1.18 $149,445 - $271,300	-229,916 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.86 - $1.7 $197,727 - $390,857	229,916 New	229,916 $253,000
Q4 2020 Feb 16, 2021	SELL	$5.05 - $7.1 $2.12 Million - $2.97 Million	-418,908 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$5.25 - $7.08 $117,426 - $158,358	22,367 Added 5.64%	418,908 $2.2 Million
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $391,473 - $591,219	72,900 Added 22.52%	396,541 $2.74 Million
Q1 2020 May 15, 2020	BUY	$4.35 - $8.79 $222,006 - $448,606	51,036 Added 18.72%	323,641 $1.84 Million
Q4 2019 Feb 14, 2020	BUY	$4.23 - $8.29 $560,559 - $1.1 Million	132,520 Added 94.6%	272,605 $2.05 Million
Q3 2019 Nov 14, 2019	BUY	$2.15 - $6.28 $301,182 - $879,733	140,085 New	140,085 $658,000
Q3 2018 Nov 14, 2018	SELL	$3.75 - $4.65 $375,000 - $465,000	-100,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.7 - $5.8 $370,000 - $580,000	100,000 New	100,000 $370,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.